Mary Oneil Mundinger Insider Profile

4 Followers
Mary Oneil Mundinger, Director at CTI BioPharma, holds ― shares in CTI BioPharma (Ticker: CTIC), holds 32.00K shares in UnitedHealth (Ticker: UNH), holds 14.89K shares in Gentiva Health Services (Ticker: GTIV).
Mary Oneil Mundinger

Mary Oneil Mundinger
CTI BioPharma (CTIC)
Director

Ranked #100,650 out of 103,103 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-158.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
100.00%
0.00%
A breakdown of Mary Oneil Mundinger's holdings

Insider Roles

UnitedHealth
(UNH)
Director
CTI BioPharma
(CTIC)
Director
Roles that Mary Oneil Mundinger holds in companies

Most Profitable Insider Trade

Stock:
CTI BioPharma
(CTIC)
Rating:Informative Sell
Date:Aug 09, 2013 - Aug 09, 2014
Return:-127.20%
The most profitable trade made by Mary Oneil Mundinger

Mary Oneil Mundinger's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CTI BioPharma
Apr 29, 2016
Director
Uninformative Buy
UnitedHealth
Director
$15.36M
GTIV
Gentiva Health Services
May 18, 2009
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Mary Oneil Mundinger's performance on stock

Mary Oneil Mundinger insider profile FAQ

What is the percentage of profitable transactions made by Mary Oneil Mundinger?
The percentage of profitable transactions made by Mary Oneil Mundinger is 0%.
    What is the average return per transaction made by Mary Oneil Mundinger?
    The average return per transaction made by Mary Oneil Mundinger is -158.90%.
      What stocks does Mary Oneil Mundinger hold?
      Mary Oneil Mundinger holds: CTIC, UNH, GTIV stocks.
        What was Mary Oneil Mundinger’s latest transaction?
        Mary Oneil Mundinger latest transaction was an Uninformative Buy of ―.
          What was Mary Oneil Mundinger's most profitable transaction?
          Mary Oneil Mundinger’s most profitable transaction was an Informative Sell of CTIC stock on August 9, 2013. The return on the trade was -127.20%.
            What is Mary Oneil Mundinger's role in CTI BioPharma?
            Mary Oneil Mundinger's role in CTI BioPharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.